Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-17

Clinical Trial Update: S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating oxaliplatin and capecitabine with radiotherapy for resectable gastric cancer was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Gastric Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-08-17